Discovery of flavoglaucin as an inhibitor of PTP-Shp2Chinese Full Text
Zhang Xue-lian;Zheng Hai-zhou;Xu Yan;Lu Xin-hua;Zhu Jing-tong;Zheng Zhi-hui;New Drug Research & Development Limited Company of North China Pharmaceutical Group Corporation,National Microbial Medicine Engineering & Research Center,Industry Microorganism Metabolites Engineering Technology of Hebei & Research Center,Shijiazhuang Engineering Laboratory for New Drugs Screening;
Abstract: Objective To discover small molecule inhibitors of protein tyrosine phosphatase Shp2(PTP-Shp2). Methods We used a high-throughput screening method to find small molecular inhibitors of PTP-Shp2 and kinetic analysis of Shp2 inhibition was implemented. We assessed the inhibitor binding sites in Shp2 using molecular docking. Results In this study, flavoglaucin was identified as a Shp2 inhibitor from products of microbial metabolism in our lab by a high-throughput screening method with an IC50<... More
Keywords:
- DOI:
10.13461/j.cnki.cja.006276
- Series:
(E) Medicine & Public Health
- Subject:
Pharmaceutics
- Classification Code:
R915
- Mobile Reading
Read on your phone instantly
Step 1
Scan QR Codes
"Mobile CNKI-CNKI Express" App
Step 2
Open“CNKI Express”
and click the scan icon in the upper left corner of the homepage.
Step 3
Scan QR Codes
Read this article on your phone.
- Download
- Online Reading
- AI Summary

Download the mobile appuse the app to scan this coderead the article.
Tips: Please download CAJViewer to view CAJ format full text.
Download: 204 Page: 683-687 Pagecount: 5 Size: 1057K
Citation Network
Related Literature
- Similar Article
- Reader Recommendation
- Associated Author
- [1]间变性淋巴瘤激酶抑制剂的药动学与治疗药物监测研究进展[J]. 迟浩华,柳芳,李沭,李博,张诚,周唯,杨萌,李朋梅. 中国医院药学杂志.
- [2]DNA修复抑制剂[J]. 药学进展. 2002(06)
- [3]利尿剂,还是ACE抑制剂?[J]. 国际医药卫生导报. 2003(09)
- [4]mTOR抑制剂的研究进展[J]. 龚晶淼. 中国实用医药. 2009(09)
- [5]胸苷酸合成酶和二氢叶酸还原酶双抑制剂的研究进展[J]. 康从民,张德华,孙宗彬,王新宇. 中国新药杂志. 2010(02)
- [6]血管紧张素转换酶(ACE)抑制剂与咳嗽[J]. 国外医药.合成药.生化药.制剂分册. 1995(06)
- [7]AChE抑制剂的疗效有限?[J]. 李元敏. 国外医学.药学分册. 1999(06)
- [8]肿瘤免疫检查点抑制剂及其联合疗法的研究进展[J]. 周姚邑,赵新新,陈沅沅,陈焱飞,王雪绒,赵轩朗,管政,高建莉. 中国药房. 2020(07)
- [9]钠-葡萄糖共转运蛋白2抑制剂类药物相关膀胱癌风险:一项上市后监测数据的真实世界分析[J]. 潘晨,曹明楠,马华瑞,廖音,崔璨,张志琪,崔向丽. 中南药学. 2022(02)
- [10]跨膜蛋白16A及其抑制剂的研究进展[J]. 狄鹏飞,陈思予,杨鸿鸣,肖庆桓,雒舒雅. 中国医科大学学报. 2024(05)